Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 29.95
+0.45 (1.53%)
At close: Jan 19, 2026
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 4.42 billion as of January 21, 2026. Its market cap has decreased by -22.89% in one year.
Market Cap
4.42B
Enterprise Value
2.94B
Revenue
12.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.95
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 4.42B, a decrease of -20.07%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 4.42B | 10.98% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Center Laboratories | 31.50B |
| Lumosa Therapeutics | 31.25B |